Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Prevention of influenza episodes with colostrum compared with vaccination in healthy and high-risk cardiovascular subjects: the epidemiologic study in San Valentino.

Cesarone MR, Belcaro G, Di Renzo A, Dugall M, Cacchio M, Ruffini I, Pellegrini L, Del Boccio G, Fano F, Ledda A, Bottari A, Ricci A, Stuard S, Vinciguerra G.

Clin Appl Thromb Hemost. 2007 Apr;13(2):130-6.

PMID:
17456621
2.

Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study.

Belcaro G, Cesarone MR, Cornelli U, Pellegini L, Ledda A, Grossi MG, Dugall M, Ruffini I, Fano F, Ricci A, Stuard S, Luzzi R, Grossi MG, Hosoi M.

Panminerva Med. 2010 Dec;52(4):269-75.

PMID:
21183886
3.

[Effectiveness of influenza vaccination in healthy adults--a fourfold decrease in influenza morbidity during one influenza season].

Chlíbek R, Beran J, Splino M.

Epidemiol Mikrobiol Imunol. 2002 Apr;51(2):47-51. Czech.

PMID:
11987579
4.

Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.

LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC Jr, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A.

Clin Ther. 2007 Aug;29(8):1579-90; discussion 1577-8.

PMID:
17919541
5.

Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients.

Looijmans-Van den Akker I, Verheij TJ, Buskens E, Nichol KL, Rutten GE, Hak E.

Diabetes Care. 2006 Aug;29(8):1771-6.

PMID:
16873778
6.

Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.

Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S.

Medicina (B Aires). 2007;67(4):351-9.

PMID:
17891930
7.
8.

Influenza vaccination coverages among children, adults, health care workers and immigrants in Spain: related factors and trends, 2003-2006.

Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, López de Andrés A, Pérez N, de Miguel AG.

J Infect. 2008 Dec;57(6):472-80. doi: 10.1016/j.jinf.2008.10.005. Epub 2008 Nov 17.

PMID:
19010553
9.

Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination.

Piñol-Ripoll G, de la Puerta I, Santos S, Purroy F, Mostacero E.

Cerebrovasc Dis. 2008;26(4):339-47. doi: 10.1159/000151636. Epub 2008 Aug 27.

PMID:
18728360
10.

[6 years' results of studying the effectiveness of preventive vaccination against influenza in cardiovascular patients at risk].

Woratz G, Müller D, Sinnecker H, Grimm J, Hajduk F, Bog R.

Z Gesamte Hyg. 1985 Dec;31(12):699-702. German. No abstract available.

PMID:
4096040
11.

Effectiveness of influenza vaccination in the elderly in South Africa.

van Vuuren A, Rheeder P, Hak E.

Epidemiol Infect. 2009 Jul;137(7):994-1002. doi: 10.1017/S0950268808001386. Epub 2008 Oct 17.

PMID:
18925986
12.

Influenza vaccination of recommended adult populations, U.S., 1989-2005.

Lu P, Bridges CB, Euler GL, Singleton JA.

Vaccine. 2008 Mar 25;26(14):1786-93. doi: 10.1016/j.vaccine.2008.01.040. Epub 2008 Feb 14.

PMID:
18336965
13.

Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.

Zhu FC, Zhou W, Pan H, Lu L, Gerez L, Nauta J, Giezeman K, de Bruijn I.

Vaccine. 2008 Aug 18;26(35):4579-84. doi: 10.1016/j.vaccine.2008.05.082. Epub 2008 Jun 17.

PMID:
18602729
14.

Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children.

Esposito S, Tremolati E, Bellasio M, Chiarelli G, Marchisio P, Tiso B, Mosca F, Pardi G, Principi N; V.I.P. Study Group.

Vaccine. 2007 Jul 20;25(29):5283-9. Epub 2007 Jun 4.

PMID:
17580099
15.

Cost-effectiveness of influenza vaccination in working-age cancer patients.

Avritscher EB, Cooksley CD, Geraci JM, Bekele BN, Cantor SB, Rolston KV, Elting LS.

Cancer. 2007 Jun 1;109(11):2357-64.

16.

Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.

Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE.

Vaccine. 2008 Sep 8;26(38):4940-6. doi: 10.1016/j.vaccine.2008.07.013. Epub 2008 Jul 26.

PMID:
18662737
17.

Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.

Scharpé J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P.

Am J Kidney Dis. 2009 Jul;54(1):77-85. doi: 10.1053/j.ajkd.2008.11.032. Epub 2009 Apr 1.

PMID:
19339089
18.

Sudden deaths following influenza vaccination: can this be expected?

van der Sande MA, van Asten L, Straus SM, Schim van der Loeff MF, Wallinga J, Conyn-van Spaendonck MA.

Vaccine. 2008 Jan 17;26(3):379-82. Epub 2007 Nov 26.

PMID:
18082296
19.

Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years.

Nichol KL, D'Heilly SJ, Greenberg ME, Ehlinger E.

Clin Infect Dis. 2009 Feb 1;48(3):292-8. doi: 10.1086/595842.

PMID:
19115970
20.

Predictors of influenza vaccination in adults with chronic bronchitis.

Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, López de Andrés A, de Miguel AG.

Respir Med. 2009 Oct;103(10):1518-25. doi: 10.1016/j.rmed.2009.04.006. Epub 2009 May 9.

Supplemental Content

Support Center